Shaun D. McMeans
Net Worth
Last updated:
What is Shaun D. McMeans net worth?
The estimated net worth of Mr. Shaun D. McMeans is at least $4,103,999 as of 1 Dec 2017. He has earned $33,299 from insider trading and has received compensation worth at least $4,070,700 in HTG Molecular Diagnostics, Inc..
What is the salary of Shaun D. McMeans?
Mr. Shaun D. McMeans salary is $407,070 per year as Senior Vice President of Fin. & Admin., Chief Financial Officer, Sec. and Treasurer in HTG Molecular Diagnostics, Inc..
How old is Shaun D. McMeans?
Mr. Shaun D. McMeans is 63 years old, born in 1962.
What stocks does Shaun D. McMeans currently own?
As insider, Mr. Shaun D. McMeans owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| HTG Molecular Diagnostics, Inc. (HTGM) | Senior Vice President of Fin. & Admin., Chief Financial Officer, Sec. and Treasurer | 42,303 | $0 | $0 |
What does HTG Molecular Diagnostics, Inc. do?
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Shaun D. McMeans insider trading
HTG Molecular Diagnostics, Inc.
Mr. Shaun D. McMeans has made 9 insider trades between 2015-2017, according to the Form 4 filled with the SEC. Most recently he sold 945 units of HTGM stock worth $1,992 on 1 Dec 2017.
The largest trade he's ever made was exercising 4,305 units of HTGM stock on 11 Mar 2016. As of 1 Dec 2017 he still owns at least 42,303 units of HTGM stock.
HTG Molecular Diagnostics key executives
HTG Molecular Diagnostics, Inc. executives and other stock owners filed with the SEC:
- Mr. Byron T. Lawson (50) Senior Vice President & Chief Commercial Officer
- Mr. John L. Lubniewski (61) Pres, Chief Executive Officer & Director
- Mr. Shaun D. McMeans (63) Senior Vice President of Fin. & Admin., Chief Financial Officer, Sec. and Treasurer